Literature DB >> 19635956

In vitro antiviral activity of V-073 against polioviruses.

M Steven Oberste1, Deborah Moore, Barbara Anderson, Mark A Pallansch, Daniel C Pevear, Marc S Collett.   

Abstract

V-073, an enterovirus capsid inhibitor, was evaluated for its spectrum of antipoliovirus activity. V-073 inhibited all 45 polioviruses tested in a virus-induced cytopathic effect protection assay, with 50% effective concentration (EC50) values ranging from 0.003 to 0.126 microM. Ninety percent of the polioviruses tested were inhibited at EC(50)s of < or = 0.076 microM (MIC90 = 32 ng/ml). V-073 is a promising antiviral candidate for the posteradication management of poliovirus incidents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635956      PMCID: PMC2764203          DOI: 10.1128/AAC.00671-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

Review 1.  A case for developing antiviral drugs against polio.

Authors:  Marc S Collett; Johan Neyts; John F Modlin
Journal:  Antiviral Res       Date:  2008-05-13       Impact factor: 5.970

2.  SCH 48973: a potent, broad-spectrum, antienterovirus compound.

Authors:  P J Buontempo; S Cox; J Wright-Minogue; J L DeMartino; A M Skelton; E Ferrari; R Albin; E J Rozhon; V Girijavallabhan; J F Modlin; J F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 3.  Inhibitors of viral uncoating.

Authors:  G D Diana; D C Pevear; M J Otto; M A McKinlay; M G Rossmann; T Smith; J Badger
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Activity of pleconaril against enteroviruses.

Authors:  D C Pevear; T M Tull; M E Seipel; J M Groarke
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

  5 in total
  18 in total

Review 1.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

2.  Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.

Authors:  Hong-Mei Liu; Jason A Roberts; Deborah Moore; Barbara Anderson; Mark A Pallansch; Daniel C Pevear; Marc S Collett; M Steven Oberste
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

3.  Immunogenicity of inactivated polio vaccine with concurrent antiviral V-073 administration in mice.

Authors:  Diana Kouiavskaia; Marc S Collett; Eugenia M Dragunsky; Andrey Sarafanov; Konstantin M Chumakov
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

4.  Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.

Authors:  Zhuoran Zhang; Enzhuo Yang; Chunmiao Hu; Han Cheng; Crystal Y Chen; Dan Huang; Richard Wang; Yue Zhao; Lijun Rong; Marco Vignuzzi; Hongbo Shen; Ling Shen; Zheng W Chen
Journal:  ACS Infect Dis       Date:  2016-11-11       Impact factor: 5.084

5.  Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.

Authors:  Zhaochun Chen; Konstantin Chumakov; Eugenia Dragunsky; Diana Kouiavskaia; Michelle Makiya; Alexander Neverov; Gennady Rezapkin; Andrew Sebrell; Robert Purcell
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

6.  In Vitro Efficacy of Antiviral Compounds against Enterovirus D68.

Authors:  Eric Rhoden; Mingyu Zhang; W Allan Nix; M Steven Oberste
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

7.  Successful treatment of fulminant neonatal enteroviral myocarditis in monochorionic diamniotic twins with cardiopulmonary support, intravenous immunoglobulin and pocapavir.

Authors:  Shahnawaz M Amdani; Hannah S Kim; Anthony Orvedahl; Audrey Odom John; Ahmed Said; Kathleen Simpson
Journal:  BMJ Case Rep       Date:  2018-05-18

8.  Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.

Authors:  Minetaro Arita; Hirotatsu Kojima; Tetsuo Nagano; Takayoshi Okabe; Takaji Wakita; Hiroyuki Shimizu
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

Review 9.  Replication and Inhibitors of Enteroviruses and Parechoviruses.

Authors:  Lonneke van der Linden; Katja C Wolthers; Frank J M van Kuppeveld
Journal:  Viruses       Date:  2015-08-10       Impact factor: 5.048

10.  Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.

Authors:  Ousmane M Diop; Cara C Burns; Steven G Wassilak; Olen M Kew
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.